R. Fernandez-botran, P. M. Chilton, and Y. Ma, Soluble cytokine receptors: their roles in immunoregulation, disease, and therapy, Adv. Immunol, vol.63, p.269, 1996.

S. A. Jones and S. Rose-john, The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex, Biochim. Biophys. Acta, vol.1592, p.251, 2002.

J. Mullberg, F. H. Durie, C. Otten-evans, M. R. Alderson, S. Rose-john et al., A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor, J. Immunol, vol.155, p.5198, 1995.

K. H. Grabstein, J. Eisenman, K. Shanebeck, C. Rauch, S. Srinivasan et al., Cloning of a T cell growth factor that interacts with the ? chain of the interleukin-2 receptor, Science, vol.264, p.965, 1994.

J. G. Giri, D. M. Anderson, S. Kumaki, L. S. Park, K. H. Grabstein et al., IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2, J. Leukocyte Biol, vol.57, p.763, 1995.

J. G. Giri, S. Kumaki, M. Ahdieh, D. J. Friend, A. Loomis et al., Identification and cloning of a novel IL-15 binding protein that is structurally related to the ? chain of the IL-2 receptor, EMBO J, vol.14, p.3654, 1995.

D. G. Norman, P. N. Barlow, M. Baron, A. J. Day, R. B. Sim et al., Three-dimensional structure of a complement control protein module in solution, J. Mol. Biol, vol.219, p.717, 1991.

T. Miyazaki, Z. J. Liu, A. Kawahara, Y. Minami, K. Yamada et al., Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation, Cell, vol.81, p.223, 1995.

J. A. Johnston, C. M. Bacon, D. S. Finbloom, R. C. Rees, D. Kaplan et al., Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15, Proc. Natl. Acad. Sci. USA, vol.92, p.8705, 1995.

B. H. Nelson and D. M. Willerford, Biology of the interleukin-2 receptor, Adv. Immunol, vol.70, p.1, 1998.

Y. Jacques, B. L. Mauff, F. Boeffard, A. Godard, and J. P. Soulillou, A soluble interleukin 2 receptor produced by a normal alloreactive human T cell clone binds interleukin 2 with low affinity, J. Immunol, vol.139, p.2308, 1987.

O. Schulz, H. F. Sewell, and F. Shakib, Proteolytic cleavage of CD25, the ? subunit of the human T cell interleukin 2 receptor, by Der p 1, a major mite allergen with cysteine protease activity, J. Exp. Med, vol.187, p.271, 1998.

B. C. Sheu, S. M. Hsu, H. N. Ho, H. C. Lien, S. C. Huang et al., A novel role of metalloproteinase in cancer-mediated immunosuppression, Cancer Res, vol.61, p.237, 2001.

R. Dummer, G. Posseckert, K. Sugamura, H. Grundmann, and G. Burg, Circulating interleukin-2 receptors are a group of multimeric proteins with immunoreactivity for interleukin-2 receptor ?, ?, and ? chains, J. Interferon Cytokine Res, vol.16, p.315, 1996.

H. Barelli, A. Petit, E. Hirsch, S. Wilk, G. De-nanteuil et al., S17092-1, a highly potent, specific and cell permeant inhibitor of human proline endopeptidase, Biochem. Biophys. Res. Commun, vol.257, p.657, 1999.

T. Hori, T. Uchiyama, M. Tsudo, H. Umadome, H. Ohno et al., Establishment of an interleukin 2-dependent human T cell line from a patient with T cell chronic lymphocytic leukemia who is not infected with human T cell leukemia/lymphoma virus, Blood, vol.70, p.1069, 1987.

T. Kitamura, T. Tange, T. Terasawa, S. Chiba, T. Kuwaki et al., Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin, J. Cell. Physiol, vol.140, p.323, 1989.

N. L. Farner, J. Gan, J. L. Jong, T. P. Leary, T. S. Fenske et al., Alteration of the CD34 ? TF-1 ? cell line profile in response to long-term exposure to IL-15, Cytokine, vol.9, p.316, 1997.

Y. Nakamura, S. M. Russell, S. A. Mess, M. Friedmann, M. Erdos et al., Heterodimerization of the IL-2 receptor ?-and ?-chain cytoplasmic domains is required for signalling, Nature, vol.369, p.330, 1994.

S. Dubois, F. Magrangeas, P. Lehours, S. Raher, J. Bernard et al., Natural splicing of exon 2 of human interleukin-15 receptor ?-chain mRNA results in a shortened form with a distinct pattern of expression, J. Biol. Chem, vol.274, p.26978, 1999.

J. Bernard, C. Harb, E. Mortier, A. Quemener, R. H. Meloen et al., Identification of an interleukin-15 ? receptor binding site on human interleukin-15, J. Biol. Chem, vol.279, p.24313, 2004.

P. J. Fraker and J. C. Speck, Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril, Biochem. Biophys. Res. Commun, vol.80, p.849, 1978.

F. Tejedor and J. P. Ballesta, Iodination of biological samples without loss of functional activity, Anal. Biochem, vol.127, p.143, 1982.

J. Mullberg, H. Schooltink, T. Stoyan, M. Gunther, L. Graeve et al., The soluble interleukin-6 receptor is generated by shedding, Eur. J. Immunol, vol.23, p.473, 1993.

M. C. Bosco, I. Espinoza-delgado, T. K. Rowe, M. G. Malabarba, D. L. Longo et al., Functional role for the myeloid differentiation antigen CD14 in the activation of human monocytes by IL-2, J. Immunol, vol.159, p.2922, 1997.

D. M. Anderson, S. Kumaki, M. Ahdieh, J. Bertles, M. Tometsko et al., Functional characterization of the human interleukin-15 receptor ? chain and close linkage of IL15RA and IL2RA genes, J. Biol. Chem, vol.270, p.29862, 1995.

R. Meazza, S. Basso, A. Gaggero, D. Detotero, L. Trentin et al., Interleukin (IL)-15 induces survival and proliferation of the growth factor-dependent acute myeloid leukemia M-07e through the IL-2 receptor ?/?, Int. J. Cancer, vol.78, p.189, 1998.

R. E. Galardy, D. Grobelny, H. G. Foellmer, and L. A. Fernandez, Inhibition of angiogenesis by the matrix metalloprotease inhibitor N-[2R-2-(hydroxamidocarbonymethyl)-4-methylpentanoyl)]-L-tryptophan methylamide, Cancer Res, vol.54, p.4715, 1994.

E. Bulanova, V. Budagian, Z. Orinska, H. Krause, R. Paus et al., Mast cells express novel functional IL-15 receptor ? isoforms, J. Immunol, vol.170, p.5045, 2003.

N. M. Hooper, E. H. Karran, and A. J. Turner, Membrane protein secretases, Biochem. J, vol.321, p.265, 1997.

J. Arribas, L. Coodly, P. Vollmer, T. K. Kishimoto, S. Rose-john et al., Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors, J. Biol. Chem, vol.271, p.11376, 1996.

J. Mullberg, H. Schooltink, T. Stoyan, P. C. Heinrich, and S. Rose-john, Protein kinase C activity is rate limiting for shedding of the interleukin-6 receptor, Biochem. Biophys. Res. Commun, vol.189, p.794, 1992.

S. A. Jones, S. Horiuchi, D. Novick, N. Yamamoto, and G. M. Fuller, Shedding of the soluble IL-6 receptor is triggered by Ca2 ? mobilization, while basal release is predominantly the product of differential mRNA splicing in THP-1 cells, Eur. J. Immunol, vol.28, p.3514, 1998.

P. O. Esteve, E. Chicoine, O. Robledo, F. Aoudjit, A. Descoteaux et al., Protein kinase C-regulates transcription of the matrix metalloproteinase-9 gene induced by IL-1 and TNF-? in glioma cells via NF-B, J. Biol. Chem, vol.277, p.35150, 2002.

R. Fernandez-botran and E. S. Vitetta, A soluble, high-affinity, interleukin-4-binding protein is present in the biological fluids of mice, Proc. Natl. Acad. Sci. USA, vol.87, p.4202, 1990.

R. Fernandez-botran and E. S. Vitetta, Evidence that natural murine soluble interleukin 4 receptors may act as transport proteins, J. Exp. Med, vol.174, p.673, 1991.

M. L. Heaney and D. W. Golde, Soluble receptors in human disease, J. Leukocyte Biol, vol.64, p.135, 1998.

T. A. Fehniger and M. A. Caligiuri, Interleukin 15: biology and relevance to human disease, Blood, vol.97, p.14, 2001.

I. B. Mcinnes, J. Mughales, M. Field, B. P. Leung, F. P. Huang et al., The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis, Nat. Med, vol.2, p.175, 1996.

Z. Liu, K. Geboes, S. Colpaert, G. R. D'haens, P. Rutgeerts et al., IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production, J. Immunol, vol.164, p.3608, 2000.

C. Agostini, L. Trentin, M. Facco, R. Sancetta, A. Cerutti et al., Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis, J. Immunol, vol.157, p.910, 1996.

S. Kakumu, A. Okumura, T. Ishikawa, M. Yano, A. Enomoto et al., Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-? (TNF-?) receptors in type C chronic liver disease, Clin. Exp. Immunol, vol.109, p.458, 1997.

L. W. Moreland, S. W. Baumgartner, M. H. Schiff, E. A. Tindall, R. M. Fleischmann et al., Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein, N. Engl. J. Med, vol.337, p.141, 1997.

X. G. Smith, E. M. Bolton, H. Ruchatz, X. Wei, F. Y. Liew et al., Selective blockade of IL-15 by soluble IL-15 receptor ?-chain enhances cardiac allograft survival, J. Immunol, vol.165, p.3444, 2000.

H. Ruchatz, B. P. Leung, X. Q. Wei, I. B. Mcinnes, and F. Y. Liew, Soluble IL-15 receptor ?-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology, J. Immunol, vol.160, p.5654, 1998.